J. Goldman & Co’s Gilead Sciences GILD Stock Holding History

J. Goldman & Co’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30,000	Closed	-$3.68M	–	739
2025 Q4	$3.68M	Sell	30,000 -57,500	-66%	-$6.99M	0.1%	236
2025 Q3	$9.71M	Buy	87,500 +31,300	+56%	+$3.56M	0.24%	123
2025 Q2	$6.23M	Buy	+56,200	New	+$5.98M	0.15%	180
2024 Q3	–	Sell	-100,000	Closed	-$6.86M	–	508
2024 Q2	$6.86M	Buy	+100,000	New	+$6.67M	0.19%	144
2024 Q1	–	Sell	-26,300	Closed	-$2.13M	–	443
2023 Q4	$2.13M	Buy	+26,300	New	+$2.05M	0.09%	184
2023 Q3	–	Sell	-52,500	Closed	-$4.05M	–	400
2023 Q2	$4.05M	Buy	+52,500	New	+$4.19M	0.15%	157
2023 Q1	–	Sell	-50,000	Closed	-$4.29M	–	409
2022 Q4	$4.29M	Buy	+50,000	New	+$3.96M	0.21%	116
2017 Q2	–	Sell	-225,000	Closed	-$15.3M	–	348
2017 Q1	$15.3M	Buy	+225,000	New	+$15.8M	0.76%	27

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

J. Goldman & Co's GILD Position: Q1 2026 in Review

J. Goldman & Co opened a new position in Gilead Sciences (GILD) in Q1 2026: 74,912 shares worth $10.4M. The stake represents 0.3% of the portfolio and ranks #105 among its holdings. This is a return to the name: J. Goldman & Co previously reported a position in GILD as recently as Q3 2025.

J. Goldman & Co first reported a position in GILD in Q1 2017 and has held it in 10 quarters since. The position peaked at $20.9M in Q3 2025. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

J. Goldman & Co held 74,912 shares of Gilead Sciences worth $10.4M as of Q1 2026.
Gilead Sciences was a new J. Goldman & Co position in Q1 2026.
Gilead Sciences made up 0.3% of J. Goldman & Co's portfolio in Q1 2026, its #105 holding.
J. Goldman & Co first reported a position in Gilead Sciences in Q1 2017 and has held it in 10 quarters since.
J. Goldman & Co's Gilead Sciences position peaked at $20.9M in Q3 2025.
2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on J. Goldman & Co's 13F filing for Q1 2026, filed 15 May 2026.